Wa. Coulter et al., DENTAL ANXIETY AND THE ABSORPTION OF ORALLY-ADMINISTERED ERYTHROMYCINSTEARATE, Oral surgery, oral medicine, oral pathology, oral radiology and endodontics, 80(6), 1995, pp. 660-665
Citations number
21
Categorie Soggetti
Pathology,Surgery,"Dentistry,Oral Surgery & Medicine
Erythromycin stearate is an acid labile antibiotic, therefore fear and
apprehension, which are known to affect gastric motility, may produce
erratic absorption resulting in lower serum levels. The mean (SD) ser
um erythromycin concentration 75 minutes after a 1.5 gm oral dose of e
rythromycin stearate to 45 patients was 8.7 (4.8) mg/L and ranged wide
ly from 0.4 to 20.5 mg/L. The serum concentration of erythromycin was
below therapeutic levels (1.0 mg/L) in two patients. No significant as
sociation was found between anxiety and serum levels of erythromycin w
hen age, gender, and gastric distress were taken into account. It is c
oncluded that dental anxiety may indirectly influence the uptake of or
al erythromycin stearate; but this relationship is complex, and there
is no evidence from this study that increased dental anxiety decreases
the uptake of the drug.